During the past decade, National Hospital Organization Kokura Medical Center conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "National Hospital Organization Kokura Medical Center" #1 sponsor was "Chugai Pharmaceutical" with 2 trials, followed by "Pfizer" with 2 trials sponsored, "JCR Pharmaceuticals Co., Ltd." with 1 trials sponsored, "Janssen Research & Development, LLC" with 1 trials sponsored and "Kyowa Kirin Co., Ltd." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "National Hospital Organization Kokura Medical Center" #1 collaborator was "Japan Lung Cancer Society" with 2 trials as a collaborator and "Japan Blood Products Organization" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "National Hospital Organization Kokura Medical Center" are "Extensive Disease Small Cell Lung Cancer" (1 trials), "Intra-abdominal Infections" (1 trials), "Mucopolysaccharidosis I" (1 trials), "Non-small Cell Lung Cancer" (1 trials) and "Non-small-Cell Lung Cancer" (1 trials). Many other conditions were trialed in "National Hospital Organization Kokura Medical Center" in a lesser frequency.

Most popular intervention types in "National Hospital Organization Kokura Medical Center" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Antithrombin gamma" (1 trials), "Ceftriaxone sodium" (1 trials), "JR-171 (lepunafusp alfa)" (1 trials), "Lumicitabine" (1 trials) and "Metronidazole" (1 trials). Other intervention names were less common.

The vast majority of trials in "National Hospital Organization Kokura Medical Center" are 6 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "National Hospital Organization Kokura Medical Center". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in National Hospital Organization Kokura Medical Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in National Hospital Organization Kokura Medical Center, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".